Key Words: mitochondria Ⅲ calcium signaling Ⅲ Ca V 1.2 expression Ⅲ arterial smooth muscle Ⅲ myogenic tone I ntracellular calcium (Ca 2ϩ ) signals modulate a wide variety of physiological functions in arterial myocytes, including contractility and gene expression. 1 The spatial location of mitochondria nearby Ca 2ϩ channels can expose these organelles to domains of elevated intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), leading to mitochondrial Ca 2ϩ uptake. 2,3 Mitochondrial Ca 2ϩ sequestration can reduce the elevation and diffusion of cytosolic Ca 2ϩ signals and feedback to alter the activity of Ca 2ϩ channels that generate the signal. 2-4 Mitochondria can also generate signaling molecules, including reactive oxygen species (ROS), which modulate local and global intracellular Ca 2ϩ signals, leading to changes in arterial contractility. 2, 3, 5 Although it is recognized that mitochondria can sequester Ca 2ϩ , intracellular Ca 2ϩ signals that regulate mitochondrial Ca 2ϩ concentration ([Ca 2ϩ ] mito ) and physiological functions of changes in [Ca 2ϩ ] mito in arterial myocytes are poorly understood.
I ntracellular calcium (Ca 2ϩ ) signals modulate a wide variety of physiological functions in arterial myocytes, including contractility and gene expression. 1 The spatial location of mitochondria nearby Ca 2ϩ channels can expose these organelles to domains of elevated intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), leading to mitochondrial Ca 2ϩ uptake. 2, 3 Mitochondrial Ca 2ϩ sequestration can reduce the elevation and diffusion of cytosolic Ca 2ϩ signals and feedback to alter the activity of Ca 2ϩ channels that generate the signal. [2] [3] [4] Mitochondria can also generate signaling molecules, including reactive oxygen species (ROS), which modulate local and global intracellular Ca 2ϩ signals, leading to changes in arterial contractility. 2, 3, 5 Although it is recognized that mitochondria can sequester Ca 2ϩ , intracellular Ca 2ϩ signals that regulate mitochondrial Ca 2ϩ concentration ([Ca 2ϩ ] mito ) and physiological functions of changes in [Ca 2ϩ ] mito in arterial myocytes are poorly understood.
Arterial myocytes generate several distinct local and global Ca 2ϩ signals. 1, 6 An elevation in global [Ca 2ϩ ] i occurs in response to plasma membrane Ca 2ϩ influx and sarcoplasmic reticulum (SR) Ca 2ϩ release and directly regulates vascular contractility. 1 Voltage-dependent Ca 2ϩ (Ca V 1.2) channels are the major contributor to global [Ca 2ϩ ] i in arterial myocytes and are essential for diameter regulation in resistance-size arteries that regulate blood pressure and regional blood flow. 1, 7, 8 Ca 2ϩ sparklets are subsarcolemmal Ca 2ϩ signals generated by Ca 2ϩ influx through Ca V 1.2 channels. 6 Ca 2ϩ sparklets contribute directly to global [Ca 2ϩ ] i , thereby regulating contractility. 6 Ca 2ϩ sparks are local Ca 2ϩ transients generated by SR ryanodine-sensitive Ca 2ϩ release channels. 1 Ca 2ϩ sparks activate large-conductance Ca 2ϩ -activated potassium channels, leading to membrane hyperpolarization and vasodilation. 1 Ca 2ϩ waves are propagating Ca 2ϩ transients that can occur because of the activation of SR inositol 1,4,5-trisphosphate receptor (IP 3 R) channels and ryanodinesensitive Ca 2ϩ channels. 9 Physiological functions of Ca 2ϩ waves are less clear, with studies reporting that these Ca 2ϩ signals either directly stimulate contraction or do not alter contractility. 10 -12 Here, we investigated Ca 2ϩ signaling mechanisms that regulate [Ca 2ϩ ] mito in myocytes of resistance-size cerebral arteries and tested the hypothesis that changes in [Ca 2ϩ ] mito control the expression of Ca V 1.2, an ion channel whose transcriptional regulation in arterial myocytes is unclear. Our data indicate that mitochondria sense IP 3 R-mediated SR Ca 2ϩ release to control mitochondrial ROS (mitoROS) generation, nuclear factor (NF)-B activity, and functional Ca V 1.2 expression in arterial myocytes.
Methods

Tissue Preparation
Animal protocols were reviewed and approved by the Animal Care and Use Committee of the University of Tennessee Health Science Center. All experiments were performed using Sprague-Dawley rat (Ϸ250 g) resistance-size (Ϸ50 to 200 m diameter) cerebral arteries or myocytes isolated from these arteries as described previously. 7
Laser-Scanning Confocal Ca 2؉ Imaging
Intracellular Ca 2ϩ signals were imaged in myocytes of cerebral arteries using fluo-4 AM and a Noran Oz laser-scanning confocal microscope, as described previously. 13 
Imaging of Genetically Encoded Fluorescent Indicators
Vectors encoding 2mt8CG2, mt-cpYFP, or HyPer-CYTO were inserted into myocytes of intact cerebral arteries using reverse permeabilization. Expressed fluorescent indicators were imaged using a Zeiss LSM5 confocal microscope. Indicator localization was determined in myocytes isolated from arteries through colocalization with MitoTracker Orange CMTMRos using weighted colocalization.
Tetramethylrhodamine Methyl Ester Imaging
Isolated arterial myocytes were loaded with tetramethylrhodamine methyl ester (TMRM) and excited with 535-nm light. Background corrected TMRM fluorescence was collected at 610 nm using a Dage MTI iCCD camera.
NF-B Immunofluorescence
Paraformaldehyde-fixed arteries were incubated with antibodies against NF-B p50 subunit (p50), followed by Cy3-conjugated secondary antibody. YOYO-1 was used to counterstain nuclei. Images were obtained using a Zeiss LSM5 confocal microscope. Weighted colocalization was used to quantify p50 nuclear localization.
NF-B-Dependent Luciferase Reporter Gene Activity
Vectors that express firefly luciferase under the control of an NF-B promoter (NF-B-p-Luc) were inserted into myocytes of intact arteries using reverse permeabilization. Promoter-deficient pGL3 Basic control vector containing a luciferase reporter gene was used as a control. Luciferase activity was quantified using a luminometer.
NF-B p105 Subunit Knockdown
Two small interfering (si)RNAs directed against NF-B p105 subunit (p105) (p105siRNA1 and p105siRNA2) were used, with scrambled siRNA (p105scrm) as control. siRNA was introduced into myocytes of intact arteries using reverse permeabilization.
Pressurized Artery Diameter Measurements
Diameter was measured in endothelial-denuded arteries using edgedetection myography. Myogenic tone (percentage) was calculated as 100ϫ(1Ϫactive diameter/passive diameter).
Statistical Analysis
OriginLab and GraphPad InStat software were used for statistical analyses. Values are expressed as meanϮSEM. Student t test was used for comparing paired and unpaired data from two populations, and ANOVA with Student-Newman-Keuls post hoc test used for multiple group comparisons. PϽ0.05 was considered significant. Power analysis was performed where PϾ0.05 to verify that sample size was sufficient to give a power value Ͼ0.8.
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results
ET-1 Modifies Local and Global Ca 2؉ Signals in Cerebral Artery Myocytes
The regulation of local and global Ca 2ϩ signals by endothelin (ET)-1, a phospholipase C-coupled receptor agonist and vasoconstrictor, was studied in myocytes of endotheliumdenuded cerebral artery segments. ET-1 reduced mean Ca 2ϩ spark frequency to Ϸ32% of control, elevated mean Ca 2ϩ wave frequency to Ϸ135% of control, and increased mean global [Ca 2ϩ ] i to Ϸ127% of control ( Figure 1A through 1D ). Xestospongin C (XeC), an IP 3 R inhibitor, blocked ET-1induced Ca 2ϩ wave activation and reduced ET-1-induced global [Ca 2ϩ ] i elevation, but did not alter ET-1-induced Ca 2ϩ spark inhibition ( Figure 1D ).
Non-standard Abbreviations and Acronyms
ET-1-Induced IP 3 R-Mediated SR Ca 2؉ Release Elevates [Ca 2؉ ] mito and Depolarizes Mitochondria in Cerebral Artery Myocytes
Regulation of [Ca 2ϩ ] mito by ET-1-induced Ca 2ϩ signals was measured in myocytes of intact arteries using 2mt8CG2 (K d for Ca 2ϩ , Ϸ5 mol/L), a genetically encoded, mitochondriatargeted, fluorescent Ca 2ϩ indicator. 14, 15 Confocal imaging revealed punctate 2mt8CG2 fluorescence that exhibited Ϸ95% pixel colocalization with MitoTracker Orange, indicating mitochondrial localization ( Figure 2A ). In myocytes of intact arteries, ionomycin, a Ca 2ϩ ionophore, and carbonyl cyanide 3-chlorophenylhydrazone (CCCP), a protonophore that disrupts mitochondrial potential, caused fluorescence changes in 2mt8CG2 consistent with the range of this indicator ( Figure 2C ). 15 ET-1 increased mean 2mt8CG2 fluorescence to Ϸ140% of control, and this elevation was blocked by thapsigargin, a SR Ca 2ϩ ATPase inhibitor, XeC, or Ru360, a mitochondrial Ca 2ϩ uniporter blocker ( Figure 2B and 2C). Thapsigargin, XeC, or Ru360 alone, or membrane depolarization (60 mmol/L K ϩ ), which elevates global [Ca 2ϩ ] i , did not alter 2mt8CG2 fluorescence ( Figure 2C ). Mitochondria potential regulation by ET-1 was studied in isolated myocytes using TMRM. ET-1 caused reproducible concentration-dependent mitochondrial depolarization with an EC 50 of 29 nmol/L ( Figure 3A through 3C). Thapsigargin and XeC abolished ET-1-induced mitochondrial depolarization, but did not alter TMRM fluorescence when applied alone ( Figure 3A and 3C). CCCP depolarized mitochondria, whereas 60 mmol/L K ϩ did not alter mitochondrial potential ( Figure 3A and 3C). These data indicate that ET-1-induced IP 3 R-mediated SR Ca 2ϩ release elevates [Ca 2ϩ ] mito and depolarizes mitochondria in arterial myocytes. In contrast, a global [Ca 2ϩ ] i elevation does not alter [Ca 2ϩ ] mito or mitochondrial potential.
ET-1-Induced IP 3 R-Mediated SR Ca 2؉ Release Stimulates mitoROS Generation
We tested the hypothesis that a [Ca 2ϩ ] mito elevation may alter mitoROS generation. MitoROS was measured using mt-cpYFP, a genetically encoded mitochondria-targeted fluorescent O 2 Ϫ⅐ indicator. 16 mt-cpYFP exhibited Ϸ95% pixel colocalization with MitoTracker Orange, indicating mitochondrial localization ( Figure 4A ). In myocytes of intact arteries, ET-1 elevated mt-cpYFP fluorescence to Ϸ199% of control, and this was blocked by XeC, Ru360, rotenone, a mitochondrial electron transport chain (ETC) complex I inhibitor, and micromolar CCCP ( Figure 4B and Online Figure I ). Rotenone and micromolar CCCP reduced mt-cpYFP fluorescence when 
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applied alone ( Figure 4B ). In contrast, Ru360, XeC, and 60 mmol/L K ϩ did not alter mt-cpYFP fluorescence ( Figure  4B ). CCCP (1 nmol/L), which induces a small mitochondrial depolarization in cerebral artery myocytes, 5 elevated mt-cpYFP fluorescence ( Figure 4B ). Cytosolic ROS was measured using HyPer-CYTO, a genetically encoded fluorescent cytosolic hydrogen peroxide (H 2 O 2 ) indicator (Online Figure II These data indicate that mitochondria generate ROS in the absence of ET-1, and that ET-1-induced IP 3 R-mediated SR Ca 2ϩ release elevates mitoROS generation, leading to an increase in cytosolic ROS in cerebral artery myocytes.
ET-1-Induced IP 3 R-Mediated mitoROS Stimulate NF-B
To examine physiological functions of an IP 3 R-mediated mitoROS elevation, we tested the hypothesis that mitochondria regulate the expression of genes that modulate myocyte contractility. Therefore, immunofluorescence was performed to study cellular localization of the p50 subunit of NF-B, a ROS-sensitive transcription factor, 19 in arterial myocytes. ET-1 increased nuclear translocation of p50, measured as an increase in mean pixel colocalization with YOYO-1 from Ϸ12% to 22% ( Figure 5A through 5C) .
To investigate the regulation of NF-B-dependent transcriptional activity, assays were performed using vectors that express firefly luciferase under the control of an NF-B promoter. As a control, regulation of luciferase activity by TNF-␣, which activates NF-B was measured. TNF-␣ increased mean luciferase activity to Ϸ547% of control ( Figure  5D ). ET-1 increased luciferase activity to Ϸ372% of control, and this was blocked by thapsigargin and XeC ( Figure 5D ). Rotenone and MnTMPyP reduced the ET-1-induced elevation in luciferase activity ( Figure 5D ). Rotenone also blocked the ET-1-induced ROS elevation over the 24-hour period used for these transcriptional measurements (Online Figure  IV) . Exogenous H 2 O 2 elevated luciferase activity, and this effect was not altered by rotenone, indicating that rotenone did not cause general inhibition of luciferase expression ( Figure 5D ). When applied alone, thapsigargin, XeC, rotenone, and MnTMPyP reduced luciferase activity by Ϸ16, 22, 23, and 20%, respectively ( Figure 5D ). TNF-␣, ET-1, thapsigargin, XeC, rotenone, MnTMPyP, and H 2 O 2 did not alter luciferase activity in arteries in which a promoter-deficient control vector was inserted (Online Figure V) . These data indicate that IP 3 R-mediated SR Ca 2ϩ release stimulates NF-B primarily by elevating mitoROS generation, but also via a secondary mitochondria-and ROS-independent pathway in arterial myocytes.
IP 3 R-Mediated SR Ca 2؉ Release Stimulates NF-B and Ca V 1.2 Expression
We sought to examine the functional significance of IP 3 Rmediated, mitochondrial-dependent NF-B activation. Ca V 1.2 channels are the principal Ca 2ϩ influx pathway in myocytes of resistance-size arteries and are essential for contractility regulation by a wide variety of stimuli, including intravascular pressure and membrane potential. 8 However, mechanisms that regulate Ca V 1.2 gene (CACNA1C) transcription in arterial myocytes are unclear. Real-time PCR data indicated that ET-1 (6 hours) increased Ca V 1.2 channel mRNA expression to Ϸ244% of control in cerebral arteries ( Figure 6A and Online Figure VI) . Western blotting indicated that ET-1 (24 hours) increased Ca V 1.2 channel (190 and 240 kDa bands) protein to Ϸ141% of control ( Figure 6B and 6C) . XeC, rotenone, and MnTMPyP alone reduced basal Ca V 1.2 expression to Ϸ87, 89 and 80% of control, respectively ( Figure 6B and 6C ). XeC blocked, and rotenone and MnT-MPyP reduced the ET-1-induced elevation in Ca V 1.2 expression ( Figure 6B and 6C) . Exogenous H 2 O 2 increased Ca V 1.2 expression, and this elevation was not altered by rotenone, 
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indicating that rotenone did not induce nonspecific inhibition of Ca V 1.2 expression ( Figure 6C ). These data indicate that ET-1-induced IP 3 R-mediated SR Ca 2ϩ release and mitoROS elevation stimulate Ca V 1.2 expression in cerebral arteries. Two different siRNAs were used to knockdown expression of p105, the p50 precursor. p105siRNA1, p105siRNA2, and a combination of both siRNAs (p105siRNAs) reduced mean p105 protein to Ϸ73, 80, and 57%, respectively, of that in arteries treated with scrambled siRNA (p105scrm) (Online Figure VII, A and B ). p105siRNAs also reduced p50 expression to Ϸ53% of p105scrm (Online Figure VIII, C and D) . p105siRNAs reduced Ca V 1.2 expression to Ϸ64% of p105scrm ( Figure 7A and 7B) . In p105scrm-treated arteries, ET-1 increased Ca V 1.2 protein to Ϸ136% of p105scrm ( Figure 7A and 7B) . p105siRNAs reduced the ET-1-induced elevation in Ca V 1.2 expression by Ϸ71% ( Figure 7A and 7B) . These data indicate that NF-B controls basal Ca V 1.2 expression and that IP 3 R-mediated SR Ca 2ϩ release stimulates Ca V 1.2 expression via mitochondria-dependent NF-B activation.
The p105 gene promoter contains an NF-B-binding sequence, and p50 activation can elevate p105 expression. 20 Therefore, mechanisms that regulate NF-B subunit expression in cerebral arteries were investigated. XeC reduced basal p105 and p50 expression, whereas rotenone or MnTMPyP did not alter basal p105 or p50 expression (Online Figure VIII, A and B). ET-1 elevated p105 and p50 expression and XeC blocked this effect (Online Figure VIII, A and B) . In contrast, rotenone or MnTMPyP had no effect on the ET-1-induced elevation in p105 and p50 subunit expression (Online Figure  VIII, B) . Exogenous H 2 O 2 applied alone or in the presence of rotenone did not change p105 and p50 expression (Online Figure  VIII, B ). p105siRNAs did not alter the ET-1-induced relative increase in p105 and p50 expression (Online Figure VIII, C and  D) . These data indicate that IP 3 R-mediated SR Ca 2ϩ release activates p105/p50 expression via a mitochondria-, ROS-, and NF-B-independent pathway. Data also indicate that rotenone, MnTMPyP, and p105siRNAs do not cause general inhibition of gene transcription.
NF-B Stimulates Functional Ca V 1.2 Expression in Cerebral Artery Myocytes
NF-B regulation of functional Ca V 1.2 expression was examined in pressurized cerebral arteries. Arteries were treated with either p105scrm or p105siRNAs and then exposed to either no further treatment or to ET-1 for 24 hours. At 60 mm Hg, control arteries (p105scrm) developed Ϸ21% myogenic tone and membrane depolarization with 60 mmol/L K ϩ elevated tone to Ϸ45%. p105 knockdown (p105siRNAs) reduced myogenic tone and depolarization-induced vasoconstriction ( Figure 7C and 7D) . A 24 hour exposure to ET-1 elevated mean myogenic tone and depolarization-induced tone in control arteries ( Figure 7C and 7D) . p105 knockdown attenuated the ET-1-induced elevation in myogenic tone and depolarization-induced vasoconstriction ( Figure 7C and 7D) . Nimodipine fully dilated arteries regardless of treatment, indicating that vasoconstriction occurred because of Ca V 1.2 channel activation ( Figure 7C and 7D) . These data indicate that NF-B is essential for functional basal Ca V 1.2 expression in cerebral artery myocytes and that ET-1-induced NF-B activation elevates Ca V 1.2-dependent vasoconstriction.
Discussion
Here, we investigated physiological signaling mechanisms that regulate [Ca 2ϩ ] mito and functional consequences of changes in [Ca 2ϩ ] mito in myocytes of resistance-size cerebral arteries. A schematic diagram summarizing major findings of this study is provided in Figure 8 . Our data indicate that ET-1-induced IP 3 R-mediated SR Ca 2ϩ release increases Ca 2ϩ wave frequency, elevates [Ca 2ϩ ] mito and depolarizes mitochondria, leading to an increase in mitoROS generation. ET-1-induced IP 3 R-mediated mitoROS elevate cytosolic ROS that increase NF-B nuclear translocation and transcriptional activity. ET-1-induced NF-B activation leads to an increase in Ca V 1.2 transcription and Ca V 1.2-dependent pressureand depolarization-induced vasoconstriction. IP 3 R-mediated SR Ca 2ϩ release, mitoROS, and NF-B control basal Ca V 1.2 expression and NF-B knockdown reduces Ca V 1.2 expression, leading to vasodilation. Collectively, these data indicate that mitochondria sense IP 3 R-mediated SR Ca 2ϩ release to control functional Ca V 1.2 channel transcription in arterial myocytes, thereby regulating arterial contractility.
Phospholipase C-coupled receptor agonists elevate IP 3 , which stimulates IP 3 Rs, and diacylglycerol, which activates protein kinase C. Vasoconstrictor-induced IP 3 R activation elevates [Ca 2ϩ ] i in arterial myocytes via 2 distinct mechanisms: (1) SR Ca 2ϩ release, which produces Ca 2ϩ waves 9, 13 ; and (2) SR Ca 2ϩ release-independent plasma membrane TRPC3 channel activation, which leads to depolarizationinduced Ca V 1.2 channel activation and a global [Ca 2ϩ ] i elevation. 13, 21, 22 In contrast, vasoconstrictor-activated protein kinase C inhibits Ca 2ϩ sparks, leading to membrane depolarization, Ca V 1.2 channel activation, and a global [Ca 2ϩ ] i elevation. 9 The regulation of arterial myocyte [Ca 2ϩ ] mito by these different intracellular Ca 2ϩ signals was unclear. Electron microscopy indicates that mitochondria can be located in close proximity (Ϸ20 nm) to the SR membrane in many cell types, including cultured arterial myocytes. 23, 24 Such localization could place mitochondria within the vicinity of SR Ca 2ϩ release channels that generate local micromolar Ca 2ϩ transients necessary for mitochondrial Ca 2ϩ uptake via the uniporter. 25 Inorganic Ca 2ϩ indicators, which cannot be targeted specifically to organelles, have been used to measure [Ca 2ϩ ] mito in cultured vascular myocytes. In these studies, SR Ca 2ϩ release elicited a [Ca 2ϩ ] mito elevation. 24, 26 Ca 2ϩ influx via the plasma membrane Na ϩ /Ca 2ϩ exchanger also elevated [Ca 2ϩ ] mito in cultured vascular myocytes. 27 In noncultured colonic myocytes, uncaging IP 3 leads to mitochondrial Ca 2ϩ uptake that feeds back to regulate IP 3 R activity. 28 To our knowledge, our study is the first to use a genetically encoded mitochondria-targeted fluorescent indicator to measure [Ca 2ϩ ] mito in contractile arterial myocytes. Our data indicate that in resting arterial myocytes, mitochondria contain Ca 2ϩ and generate low levels of ROS through mechanisms that are independent of IP 3 R-mediated SR Ca 2ϩ release. ET-1-induced IP 3 R-mediated SR Ca 2ϩ release stimulated Ca 2ϩ waves and elevated [Ca 2ϩ ] mito , leading to mitochondrial depolarization and mitoROS generation. In contrast, a global [Ca 2ϩ ] i elevation did not alter [Ca 2ϩ ] mito , mitochondrial potential, or mitoROS generation. These findings also raise the possibility that Ca 2ϩ waves specifically regulate [Ca 2ϩ ] mito in arterial myocytes. Given that Ca 2ϩ waves are propagating Ca 2ϩ signals, [Ca 2ϩ ] mito may also oscillate. Here, [Ca 2ϩ ] mito was simultaneously measured within multiple myocytes in the arterial wall. Asynchronous Ca 2ϩ oscillations within individual mitochondria would have been averaged out by the imaging protocol. Future studies should be designed to examine spatial and temporal relationships between Ca 2ϩ waves and mitochondrial Ca 2ϩ signals within individual mitochondria in arterial myocytes.
The mechanism by which mitochondrial Ca 2ϩ uptake induces mitochondrial depolarization and elevates mitochondrial electron transport chain-generated mitoROS was not determined, but several possibilities exist. Mitochondrial depolarization has been demonstrated to increase or decrease ROS in different cell types, including vascular myocytes. 5, 16, 17, 29 Here, a small mitochondrial depolarization increased mitoROS generation, whereas a large mitochondrial depolarization inhibited mitoROS production, consistent with an earlier report in cerebral artery myocytes. 5 A [Ca 2ϩ ] mito elevation may stimulate mitoROS generation through multiple mechanisms, including stimulation of the tricarboxylic acid cycle. 29 In addition, a [Ca 2ϩ ] mito elevation and mitochondrial depolarization can open the mitochondrial permeability transition pore, 29, 30 which in turn can enhance depolarization. 29 Mitochondrial permeability transition pore opening elevates mitoROS generation via several pathways, including dissipation of chemical gradients across the mitochondrial membrane and diversion of electrons in the mitochondrial electron transport chain to ROS generation. 16 Therefore, a [Ca 2ϩ ] mito elevation and mitochondrial depolarization may stimulate mitoROS generation by opening the mitochondrial permeability transition pore. MitoROS production is also regulated by multiple additional factors, including redox status of respiratory substrates, and proton pumping by mitochondrial electron transport chain complexes. 31 Future investigations should examine the mechanisms by which a vasoconstrictor-induced [Ca 2ϩ ] mito elevation and mitochondrial depolarization stimulate mitoROS generation.
Regulation and physiological functions of NF-B in contractile arterial myocytes are poorly understood. Data here indicate that ET-1-induced NF-B activation occurs primarily via IP 3 R-mediated mitoROS generation in cerebral artery myocytes. MitoROS activate NF-B in several cell types, including cultured vascular myocytes. 19, 32 Alternate ROSmediated mechanisms can also activate NF-B. For example, following balloon injury, NAD(P)H oxidase-derived ROS stimulate NF-B in arterial myocytes. 33 The mechanisms by which ROS activate NF-B are unclear, with reports suggesting that ROS stimulate IB kinase, leading to phosphoryla-tion and proteasomal degradation of IB. 32 Other studies indicate that ROS activate kinases other than IB kinase to phosphorylate IB. 34 Additional studies will be necessary to identify the specific ROS involved and the mechanisms by which ROS activate NF-B in contractile arterial myocytes. Data reported here indicate that IP 3 R-mediated SR Ca 2ϩ release also activates NF-B via a secondary mitoROSindependent pathway. Supporting bimodal activation, redoxdependent and -independent mechanisms activate NF-B in U937 cells. 35 Redox-independent NF-B activation mechanisms may be mediated by calcineurin, PI3K/Akt, and/or protein kinase C, as demonstrated in neurons. 36 Ca V 1.2 channels are the principal functional Ca 2ϩ influx pathway in myocytes of resistance-size arteries. 1, 7, 8 Our data indicate that basal Ca V 1.2 expression is controlled through both an IP 3 R-mediated mitochondria-independent pathway and an IP 3 R-independent mitoROS pathway acting through NF-B. ET-1-induced IP 3 R activation stimulates an NF-B-dependent elevation in Ca V 1.2 expression primarily via a mitoROS-dependent pathway and via a secondary mitochondria-independent pathway. In the absence of phospholipase C-coupled receptor ligands, intracellular IP 3 concentration ([IP 3 ] i ) and thus, IP 3 R activity should be low. However, in the intact artery preparation studied here endothelial cell release of receptor ligands, including ET-1, may generate low levels of [IP 3 ] i in myocytes. In our experiments, the degree of p105 knockdown and the reduction in basal Ca V 1.2 expression were similar, indicating that NF-B is a major Ca V 1.2 gene transcription activator in arterial myocytes. In contrast, in colonic myocytes NF-B p50 and p65 subunit activation reduced Ca V 1.2 expression. 37 Opposing regulation by NF-B in these different myocyte types may occur through interaction with different B binding motifs, of which there are several upstream of the Ca V 1.2 gene. 37 Furthermore, the presence or absence of additional transcriptional activators and/or repressors may explain differential regulation of Ca V 1.2 expression by NF-B. Our data also indicate that ET-1-induced IP 3 R-mediated SR Ca 2ϩ release stimulates NF-B subunit expression through a mitochondria-, ROS-, and NF-B-independent pathway. The ET-1-induced elevation in NF-B expression may serve to amplify Ca V 1.2 expression. In rat renal arteries, membrane depolarization increased Ca V 1.2 protein, 38 whereas, here, IP 3 Rs were necessary for ET-1-induced elevation in Ca V 1.2 expression. Data from these studies raise several possibilities, including that local and global Ca 2ϩ signals regulate Ca V 1.2 expression by different mechanisms in cerebral and renal artery myocytes. Conceivably, this could occur at many levels, including that global Ca 2ϩ may regulate [Ca 2ϩ ] mito in renal artery myocytes, leading to ROS generation and NF-B activation.
Data reported here and in previous studies suggest that vasoconstrictors cause a similar shift in local and global Ca 2ϩ signals in myocytes of anatomically different arteries. 9, 39 Therefore, IP 3 R regulation of Ca 2ϩ waves, [Ca 2ϩ ] mito , and mitoROS generation may be a common mechanism by which vasoconstrictors regulate myocyte NF-B activity and functional Ca V 1.2 expression. IP 3 R-mediated SR Ca 2ϩ release and local Ca 2ϩ influx through Ca V 1.2 channels also stimulates calcineurin-dependent nuclear translocation of NFATc3 (nuclear factor of activated T cell c3) in arterial myocytes. 40, 41 Data here not only indicate that IP 3 Rs control physiological Ca V 1.2 expression via a mitoROS/NF-B pathway but also raise the possibility that disease-associated alterations in ion channel expression may also occur through activation of this pathway. Many vasoconstrictors, including ET-1, are elevated in cardiovascular diseases, including systemic hypertension. 42 Hypertension is also associated with an increase in vascular ROS, NF-B activity, and Ca V 1.2 protein and currents. [43] [44] [45] Therefore, targeting this transcriptional pathway may be beneficial in treating cardiovascular diseases.
In summary, this study indicates that mitochondria sense IP 3 R-mediated SR Ca 2ϩ release to control the activity of NF-B, which stimulates functional Ca V 1.2 expression in cerebral artery myocytes.
